XBIO Xenetic Biosciences, Inc.

Fundamentals / CIK 0001534525 / USD

Xenetic Biosciences, Inc. reported $2.96M in revenue and a net loss of $3.66M for the trailing twelve months ended September 30, 2026 (down 29.4% year over year), with a -129.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$13.20M$6.60M$0-$51.33MFY 2016 Revenue: $3.00MFY 2016 Net Income: -$54.21M2016FY 2017 Revenue: $7.58MFY 2017 Net Income: -$3.60M2017FY 2018 Revenue: $0FY 2018 Net Income: -$7.30M2018FY 2019 Revenue: $17KFY 2019 Net Income: -$12.78M2019FY 2020 Revenue: $437KFY 2020 Net Income: -$10.89M2020FY 2021 Revenue: $1.16MFY 2021 Net Income: -$5.65M2021FY 2022 Revenue: $1.71MFY 2022 Net Income: -$6.55M2022FY 2023 Revenue: $2.54MFY 2023 Net Income: -$4.13M2023FY 2024 Revenue: $2.50MFY 2024 Net Income: -$3.96M2024FY 2025 Revenue: $2.98MFY 2025 Net Income: -$2.68M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.98M $2.50M $2.54M $1.71M $1.16M $437K $17K $0 $7.58M $3.00M
Research & Development $3.07M $3.29M $3.49M $4.77M $3.16M $1.73M $4.89M $2.88M $4.06M $43.74M
Total Operating Expenses $5.81M $6.70M $7.06M $8.42M $6.91M $14.37M $12.90M $7.28M -- --
Operating Income -$2.83M -$4.20M -$4.52M -$6.72M -$5.75M -$13.94M -$12.89M -$7.28M -$3.57M -$47.43M
EBITDA -- -- -- -$6.72M -$5.75M -$13.94M -$12.88M -$7.26M -$3.54M -$47.39M
Interest Income -- -- -- -- -- -- -- -- $17K $32
Interest Expense -- -- -- -- -- -- -- -- $1.8K $730K
Income Tax Expense $0 $0 $0 $0 $0 -$2.92M $0 $0 $0 $0
Net Income -$2.68M -$3.96M -$4.13M -$6.55M -$5.65M -$10.89M -$12.78M -$7.30M -$3.60M -$54.21M
Basic EPS -$1.58 -$2.57 -$2.71 -$4.61 -$5.50 -$17.00 -$63.30 -$1,159.66 -$49.22 -$941.18
Diluted EPS -$1.58 -$2.57 -$2.71 -$4.61 -$5.50 -$17.00 -$63.30 -$1,159.66 -$49.22 -$941.18
Basic Shares Outstanding 1.7M 1.5M 1.5M 1.4M 1.0M 639.2K 285.2K 6.3K 72.2K 61.9K
Diluted Shares Outstanding 1.7M 1.5M 1.5M 1.4M 1.0M 639.2K 285.2K 6.3K 72.2K 61.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $725K $661K $807K $766K $1.03M $590K $593K $649K
Research & Development $521K $552K $661K $773K $756K $657K $879K $1.04M
Total Operating Expenses $2.46M $1.63M $1.31M $1.39M $1.57M $1.31M $1.54M $1.75M
Operating Income -$1.74M -$972K -$502K -$623K -$545K -$724K -$942K -$1.10M
Interest Income -- $42K $46K -- -- $34K $39K --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$1.70M -$930K -$456K -$579K -$510K -$689K -$903K -$1.05M
Basic EPS -$0.72 -$0.41 -$0.20 -- -$0.33 -$0.45 -$0.59 --
Diluted EPS -$0.72 -$0.41 -$0.20 -- -$0.33 -$0.45 -$0.59 --
Basic Shares Outstanding 2.3M 2.3M 2.3M -- 1.5M 1.5M 1.5M --
Diluted Shares Outstanding 2.3M 2.3M 2.3M -- 1.5M 1.5M 1.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.88M $6.17M $8.98M $13.10M $18.24M $11.53M $10.37M $572K $5.53M $4.05M
Cash & Short-Term Investments $7.88M $6.17M $8.98M $13.10M $18.24M $11.53M $10.37M $572K $5.53M $4.05M
Accounts Receivable, Net -- -- -- -- -- -- -- -- $0 $3.00M
Total Current Assets $8.05M $6.59M $9.59M $13.65M $18.72M $12.37M $11.09M $1.19M $5.88M $8.34M
Property, Plant & Equipment, Net -- -- -- $0 $0 $0 $757 $5.0K $28K $42K
Goodwill -- -- -- -- -- $0 $9.24M $3.28M $3.28M $3.28M
Other Non-Current Assets $314K $314K $1.02M $1.07M $1.09M $810K $1.21M $706K $725K $66K
Total Non-Current Assets $314K $314K $1.02M $1.07M $1.09M $810K $10.46M $13.24M $13.28M $12.64M
Total Assets $8.36M $6.90M $10.61M $14.72M $19.82M $13.18M $21.55M $14.43M $19.16M $20.97M
Accounts Payable $258K $284K $241K $287K $362K $327K $931K $934K $787K $1.01M
Other Current Liabilities -- -- -- -- -- -- -- $666K $21K $20K
Total Current Liabilities $968K $894K $810K $1.07M $1.42M $937K $1.42M $1.60M $1.94M $1.87M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0 $0 $20K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $27K $2.92M $2.92M $2.92M $2.94M
Total Liabilities $968K $894K $810K $1.07M $1.42M $964K $4.33M $4.52M $4.86M $4.80M
Total Debt (incl. Leases) -- -- -- -- -- $63K $20K -- -- --
Common Stock $2.3K $1.5K $1.5K $1.5K $13K $8.8K $6.1K $811 $9.0K $8.7K
Retained Earnings -$199.9M -$197.2M -$193.2M -$189.1M -$182.5M -$176.9M -$166.0M -$153.2M -$145.9M -$142.3M
Accumulated Other Comp. Income $254K $254K $254K $254K $254K $254K $254K $254K $254K $254K
Total Stockholders' Equity $7.40M $6.01M $9.80M $13.65M $18.39M $12.22M $17.21M $9.91M $14.30M $16.17M
Total Equity $7.40M $6.01M $9.80M $13.65M $18.39M $12.22M $17.21M $9.91M $14.30M $16.17M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- -- $7.35M $7.88M -- -- $5.16M $6.17M
Cash & Short-Term Investments -- -- $7.35M $7.88M -- -- $5.16M $6.17M
Total Current Assets $6.00M $6.65M $7.60M $8.05M $5.07M $5.35M $5.48M $6.59M
Other Non-Current Assets $314K $314K $314K $314K $0 $0 $314K $314K
Total Non-Current Assets $314K $314K $314K $314K $0 $0 $314K $314K
Total Assets $6.32M $6.97M $7.91M $8.36M $5.07M $5.35M $5.79M $6.90M
Accounts Payable $1.41M $323K $559K $258K $578K $347K $240K $284K
Total Current Liabilities $1.90M $895K $958K $968K $1.11M $903K $668K $894K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $1.90M $895K $958K $968K $1.11M $903K $668K $894K
Common Stock $2.3K $2.3K $2.3K $2.3K $1.5K $1.5K $1.5K $1.5K
Retained Earnings -$203.0M -$201.3M -$200.3M -$199.9M -$199.3M -$198.8M -$198.1M -$197.2M
Accumulated Other Comp. Income $254K $254K $254K $254K $254K $254K $254K $254K
Total Stockholders' Equity $4.41M $6.07M $6.95M $7.40M $3.96M $4.45M $5.12M $6.01M
Total Equity $4.41M $6.07M $6.95M $7.40M $3.96M $4.45M $5.12M $6.01M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$2.68M -$3.96M -$4.13M -$6.55M -$5.65M -$13.81M -$12.78M -$7.30M -$3.60M -$54.21M
Depreciation & Amortization -- -- -- $0 $0 $1.0K $4.2K $16K $24K $36K
Stock-Based Compensation $65K $172K $283K $511K $410K $469K $806K $1.36M $1.78M $1.92M
Change in Receivables -- -- -- -- -- -- -- $0 $3.00M -$3.00M
Operating Cash Flow -$2.29M -$2.82M -$4.11M -$4.65M -$4.74M -$4.27M -$6.40M -$6.46M $1.49M -$8.79M
Capital Expenditure -- -- -- -- -- -- -- $0 -$9.3K -$17K
Free Cash Flow -- -- -- -- -- -- -- -$6.46M $1.48M -$8.80M
Investing Cash Flow -- -- $0 -$500K $0 $0 $2.0K $22K -$9.3K -$17K
Common Stock Issued $4.00M $0 -- $0 $11.45M $5.43M $0 $0 -- --
Financing Cash Flow $4.00M $0 -- $0 $11.45M $5.43M $16.13M $1.48M $0 $12.72M
Net Change in Cash $1.72M -$2.82M -$4.11M -$5.15M $6.72M $1.16M $9.73M -$4.96M $1.48M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.70M -$930K -$456K -$579K -$510K -$689K -$903K -$1.05M
Stock-Based Compensation $36K $52K $11K $14K $16K $16K $19K $25K
Operating Cash Flow -$662K -$875K -$536K -$243K -$658K -$384K -$1.00M -$674K
Net Change in Cash -$662K -$875K -$536K $3.76M -$658K -$384K -$1.00M -$674K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -95.2% -168.2% -177.8% -393.6% -495.1% -3189.8% -75511.7% -- -47.1% -1581.0%
Net Profit Margin -90.1% -158.4% -162.8% -383.9% -486.4% -2493.1% -74856.6% -- -47.4% -1806.9%
Return on Equity (ROE) -36.2% -65.9% -42.2% -48.0% -30.7% -89.2% -74.2% -73.6% -25.1% -335.2%
Return on Assets (ROA) -32.1% -57.4% -39.0% -44.5% -28.5% -82.7% -59.3% -50.6% -18.8% -258.4%
Current Ratio 8.32x 7.37x 11.84x 12.72x 13.18x 13.20x 7.84x 0.75x 3.03x 4.47x
Quick Ratio 8.14x 6.89x 11.10x 12.20x 12.84x 12.30x 7.33x 0.36x 2.85x 3.78x
Debt to Equity -- -- -- -- -- 0.01x 0.00x -- -- --
Revenue Growth (YoY) +19.0% -1.6% +48.8% +47.1% +165.6% +2460.3% -- -100.0% +152.8% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -532.6% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -535.3% -- --
5Y Revenue / Share Growth +155.9% +2611.3% -- -98.9% -97.7% -- -- -100.0% +35623.0% --
10Y Revenue / Share Growth -- -- +65.9% +308.0% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -129.6% -81.0% -75.1% -95.2% -115.8% -133.5% -150.2% -168.2%
Net Profit Margin -123.7% -75.9% -70.0% -90.1% -110.4% -126.0% -142.0% -158.4%
Return on Equity (ROE) -82.9% -40.8% -32.1% -36.2% -79.8% -69.3% -71.6% -65.9%
Return on Assets (ROA) -57.9% -35.5% -28.2% -32.1% -62.3% -57.6% -63.3% -57.4%
Current Ratio 3.15x 7.43x 7.93x 8.32x 4.56x 5.93x 8.20x 7.37x
Quick Ratio -- -- 7.67x 8.14x -- -- 7.73x 6.89x
Revenue Growth (YoY) -29.4% +12.0% +36.0% +18.1% +67.2% -18.8% +16.1% -3.4%
Source: SEC EDGAR CompanyFacts (CIK 0001534525) · from August 31, 2011 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal